nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
7 ABS: What have we learned from long-term results of prostate brachytherapy ?
|
|
|
2004 |
71 |
S2 |
p. S3- 1 p. |
artikel |
2 |
64 Accelerated partial breast irradiation (APBI): is it ready for prime time ?
|
|
|
2004 |
71 |
S2 |
p. S32- 1 p. |
artikel |
3 |
65 Accelerated partial breast irradiation (APB): ready for prime time ?
|
|
|
2004 |
71 |
S2 |
p. S32-S33 2 p. |
artikel |
4 |
Author index
|
|
|
2004 |
71 |
S2 |
p. S141-S147 7 p. |
artikel |
5 |
59 Brachytherapy as monotherapy in localised prostate cancer, permanent seed implantation or high dose rate ?
|
|
|
2004 |
71 |
S2 |
p. S29-S30 2 p. |
artikel |
6 |
170 Cervical cancer: experience in the department of radiation oncology. H.U. “Reina Sofia” Cordoba
|
|
|
2004 |
71 |
S2 |
p. S79-S80 2 p. |
artikel |
7 |
57 Clinical confirmation that “HDR” monotherapy may be the best accelerated-hypofractionated treatment for prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S28- 1 p. |
artikel |
8 |
27 Clinical validation of TG-43 data treatment planning algorithms
|
|
|
2004 |
71 |
S2 |
p. S13- 1 p. |
artikel |
9 |
58 Combined external beam radiation and intensity modulated HDR-brachytherapy boost for localized prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S28-S29 2 p. |
artikel |
10 |
26 Consideration of the updated TG-43 brachytherapy dosimetry formalism
|
|
|
2004 |
71 |
S2 |
p. S13- 1 p. |
artikel |
11 |
100 Defining low/high dose rate as if biology mattered
|
|
|
2004 |
71 |
S2 |
p. S50- 1 p. |
artikel |
12 |
29 3D Imaging based treatment planning in brachytherapy, the next generation or what next to TG-43
|
|
|
2004 |
71 |
S2 |
p. S14-S15 2 p. |
artikel |
13 |
32 Following my way in curie therapy — Tarragona 1950 through Houston 1996
|
|
|
2004 |
71 |
S2 |
p. S16- 1 p. |
artikel |
14 |
6 GLAC: combined chemoradiotherapy and brachytherapy in locally advanced cervical cancer
|
|
|
2004 |
71 |
S2 |
p. S3- 1 p. |
artikel |
15 |
61 Interstitial brachytherapy for breast cancer: technical issues & avoiding pitfalls
|
|
|
2004 |
71 |
S2 |
p. S31- 1 p. |
artikel |
16 |
171 Intracavitary brachytherapy for endometrial cancer. Experience in the department of Radiation Oncology. H.U. “Reina Sofia”, Cordoba
|
|
|
2004 |
71 |
S2 |
p. S80- 1 p. |
artikel |
17 |
98 LDR brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S49- 1 p. |
artikel |
18 |
63 Mammosite: technical factors and outcome — European experience
|
|
|
2004 |
71 |
S2 |
p. S31-S32 2 p. |
artikel |
19 |
76 oral Accelerated partial breast irradiation with 192-iridium multicatheter PDR-/HDR-brachytherapy. 2-year results of the German-Austrian multicenter trial
|
|
|
2004 |
71 |
S2 |
p. S38- 1 p. |
artikel |
20 |
92 oral A comparison between Paris, SSDS and target optimised dosimetry for interstitial brachytherapy breast boost
|
|
|
2004 |
71 |
S2 |
p. S46- 1 p. |
artikel |
21 |
12 oral A comparison of automated and manual dose-volume data extraction for HDR prostate patients: implications for tolerance data
|
|
|
2004 |
71 |
S2 |
p. S5-S6 2 p. |
artikel |
22 |
115 oral Adjuvant HDR brachytherapy after external beam radiotherapy in 182 with nasopharyngeal cancer patients
|
|
|
2004 |
71 |
S2 |
p. S57- 1 p. |
artikel |
23 |
49 oral Adjuvant treatment with external radiotherapy and high-dose-rate brachytherapy in patients with endometrial tumours previously treated with surgery. Analysis of results and secondary effects
|
|
|
2004 |
71 |
S2 |
p. S23-S24 2 p. |
artikel |
24 |
16 oral Advanced cervical carcinoma treated by external beam radiotherapy and high dose rate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S7- 1 p. |
artikel |
25 |
96 oral A method for checking HDR brachytherapy treatment plans
|
|
|
2004 |
71 |
S2 |
p. S47-S48 2 p. |
artikel |
26 |
105 oral Analysis of acute and late morbidity, and biochemical control for intermediate to high risk prostate cancer treated with androgen deprivation, HDR and 3D/IMRT: 4 year results of a phase I-II dose escalation trial
|
|
|
2004 |
71 |
S2 |
p. S52-S53 2 p. |
artikel |
27 |
72 oral An economic evaluation of interstitial brachytherapy, radical prostatectomy and external beam radiotherapy for localized prostate cancer : results during the first year after therapy
|
|
|
2004 |
71 |
S2 |
p. S36-S37 2 p. |
artikel |
28 |
97 oral A novel beta particle silicon dosimeter
|
|
|
2004 |
71 |
S2 |
p. S48- 1 p. |
artikel |
29 |
8 oral A prostate phantom for quality control of MR and CT based postimplant seed reconstruction
|
|
|
2004 |
71 |
S2 |
p. S4- 1 p. |
artikel |
30 |
43 oral A retrospective comparison of the use of androgen deprivation among low and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
|
|
|
2004 |
71 |
S2 |
p. S21- 1 p. |
artikel |
31 |
9 oral Assessment of prostate volume determining parameters in I-125 therapy
|
|
|
2004 |
71 |
S2 |
p. S4- 1 p. |
artikel |
32 |
13 oral A systematic quality control of seed dosimetry with an automatic needle loading system for permanent prostate implant
|
|
|
2004 |
71 |
S2 |
p. S6- 1 p. |
artikel |
33 |
11 oral Automatic seed localization, using MR images, for post implant assessment following prostate seed implantation
|
|
|
2004 |
71 |
S2 |
p. S5- 1 p. |
artikel |
34 |
67 oral Biologic image (MRSI) guided intraoperative computer optimized -directed dose escalation for transperineal permanent interstitial prostate implantation
|
|
|
2004 |
71 |
S2 |
p. S34- 1 p. |
artikel |
35 |
77 oral Brachytherapy for accelerated partial breast irradiation: factors affecting toxicity and cosmesis
|
|
|
2004 |
71 |
S2 |
p. S38-S39 2 p. |
artikel |
36 |
124 oral Brachytherapy for penile cancer: results for 49 patients
|
|
|
2004 |
71 |
S2 |
p. S61-S62 2 p. |
artikel |
37 |
93 oral Can we rely on source holder correction factors given by the well chamber vendor?
|
|
|
2004 |
71 |
S2 |
p. S46- 1 p. |
artikel |
38 |
104 oral Chronic toxicity profile and biochemical outcome in favorable-stage prostate cancer patients undergoing monotherapy with HDR or LDR (Pd103) brachytherapy at William Beaumont Hospital
|
|
|
2004 |
71 |
S2 |
p. S52- 1 p. |
artikel |
39 |
116 oral Combined external beam radiation therapy and HDR intracavitary brachytherapy boost in nasopharyngeal cancer: a retrospective analysis
|
|
|
2004 |
71 |
S2 |
p. S58- 1 p. |
artikel |
40 |
23 oral Combined MRI-based intracavitary and interstitial brachyterapy for locally advanced cervical cancer with a modified tandem ring applicator- clinical feasibility and preliminary results
|
|
|
2004 |
71 |
S2 |
p. S10-S11 2 p. |
artikel |
41 |
18 oral Comparison of twelve-year treatment results of advanced cervical carcinoma with Californium-252 vs. gamma radiation only in brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S8- 1 p. |
artikel |
42 |
45 oral Comparison of two low dose rates in vaginal prophylactic pre-operative brachytherapy for patients with stage I-II endometrial carcinoma : long-term results of a randomised trial
|
|
|
2004 |
71 |
S2 |
p. S22- 1 p. |
artikel |
43 |
37 oral Comparison of 5-year outcomes between conformal LDR brachytherapy and high dose IMRT for patients with clinically localized prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S18- 1 p. |
artikel |
44 |
107 oral Comprehensive quality of life comparison between high dose conformal radiotherapy and intraoperative-planned conformal brachytherapy for patients with localized prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S54- 1 p. |
artikel |
45 |
54 oral Consequences of brachytherapy (BT) on uterine myocontractility
|
|
|
2004 |
71 |
S2 |
p. S26- 1 p. |
artikel |
46 |
52 oral Conservative treatment for vulvar cancer: chemoradiation and high dose rate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S25- 1 p. |
artikel |
47 |
111 oral Decreased incidence of urinary retention after prostate brachytherapy: the effect of learning curve?
|
|
|
2004 |
71 |
S2 |
p. S55-S56 2 p. |
artikel |
48 |
66 oral 3-dimensional MR spectroscopic imaging of prostate pre and post brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S34- 1 p. |
artikel |
49 |
42 oral Dose escalation and toxicity limitation in prostate cancer therapy: conforming external beam treatment to dose delivered to prostate and critical adjacent normal structures by I-125 permanent implants
|
|
|
2004 |
71 |
S2 |
p. S20-S21 2 p. |
artikel |
50 |
22 oral Dose parameters for MRI based treatment planning — Analysis of 93 individual fractions in HDR cervix cancer brachytherapy for 22 patients
|
|
|
2004 |
71 |
S2 |
p. S9-S10 2 p. |
artikel |
51 |
79 oral Dose-volume evaluation of HDR interstitial breast implants planned by traditional and image-based dosimetry systems
|
|
|
2004 |
71 |
S2 |
p. S39-S40 2 p. |
artikel |
52 |
35 oral Early biochemical outcome following permanent interstitial brachytherapy as monotherapy in T1-T2 prostate cancer: results of a collaborative group on prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S17-S18 2 p. |
artikel |
53 |
109 oral Early urinary morbidity after I125 transperineal interstitial permanent prostate brachytherapy. A multivariate analysis of 600 patients treated by the Institut Curie / Hopital Cochin/Hopital Necker Paris group
|
|
|
2004 |
71 |
S2 |
p. S54-S55 2 p. |
artikel |
54 |
108 oral Effect of multiple variables on acute urinary morbidity following permanent I-125 implantation of the prostate: insights from a prospective, randomized trial
|
|
|
2004 |
71 |
S2 |
p. S54- 1 p. |
artikel |
55 |
126 oral Endovascular Brachytherapy with 192Iridium after Femoropopliteal-Stenting. Results from the Vienna-5 Trial
|
|
|
2004 |
71 |
S2 |
p. S62- 1 p. |
artikel |
56 |
112 oral Erectile dysfunction (ED) after prostate cancer brachytherapy as sole treatment modality. The William Beaumont Hospital's experience with HDR vs. LDR (Pd103 permanent implants)
|
|
|
2004 |
71 |
S2 |
p. S56- 1 p. |
artikel |
57 |
118 oral Exclusive LDR brachytherapy in 279 patients with T2N0 tongue carcinoma
|
|
|
2004 |
71 |
S2 |
p. S59- 1 p. |
artikel |
58 |
56 oral Factors influencing local failure and long-term outcomes among patients receiving high dose rate Iridium-192 intraoperative brachytherapy for colorectal adenocarcinoma
|
|
|
2004 |
71 |
S2 |
p. S27- 1 p. |
artikel |
59 |
71 oral Factors predicting for urinary incontinence following prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S36- 1 p. |
artikel |
60 |
122 oral First report of an institutional phase I-II trial of perioperative fractionated HDR brachytherapy (PHDRB)
|
|
|
2004 |
71 |
S2 |
p. S60-S61 2 p. |
artikel |
61 |
70 oral Genito-urinary and gastro-intestinal toxicity after inverse planned permanent prostate implant with high activity seeds
|
|
|
2004 |
71 |
S2 |
p. S35-S36 2 p. |
artikel |
62 |
125 oral Gliasite radiotherapy system for treatment of recurrent malignant glioma: a multi-institutional analysis
|
|
|
2004 |
71 |
S2 |
p. S62- 1 p. |
artikel |
63 |
17 oral High dose rate brachytherapy in the management of cervix cancer
|
|
|
2004 |
71 |
S2 |
p. S7-S8 2 p. |
artikel |
64 |
117 oral High dose rate brachytherapy with stiff applicators in the treatment of nasopharyngeal lymphoepithelioma in childhood
|
|
|
2004 |
71 |
S2 |
p. S59- 1 p. |
artikel |
65 |
121 oral High dose rate (HDR) interstitial brachytherapy for stage III and IV head and neck cancers
|
|
|
2004 |
71 |
S2 |
p. S60- 1 p. |
artikel |
66 |
21 oral Imaging the non-displaced rectosigmoid during HDR brachytherapy for cervical cancer can alter dose specification
|
|
|
2004 |
71 |
S2 |
p. S9- 1 p. |
artikel |
67 |
41 oral Impact of hormone therapy on post implant dosimetry and outcome following I-125 implant monotherapy for localised prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S20- 1 p. |
artikel |
68 |
39 oral Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for low and intermediate-risk adenocarcinoma of the prostate
|
|
|
2004 |
71 |
S2 |
p. S19- 1 p. |
artikel |
69 |
110 oral Influence of intraoperative prostate volume on early urinary toxicity after permanent prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S55- 1 p. |
artikel |
70 |
69 oral Influence of postoperative dosimetric parameters on acute and chronic toxicity following peripheral loading brachytherapy with stranded iodine seeds
|
|
|
2004 |
71 |
S2 |
p. S35- 1 p. |
artikel |
71 |
24 oral Initial clinical results of inverse planned high dose rate interstitial implants for cervical cancer
|
|
|
2004 |
71 |
S2 |
p. S11- 1 p. |
artikel |
72 |
25 oral Intercomparison of treatment concepts for 3D image guided brachytherapy of cervical carcinoma based on a GEC-ESTRO study protocol
|
|
|
2004 |
71 |
S2 |
p. S11-S12 2 p. |
artikel |
73 |
50 oral Intravaginal HDR brachytherapy alone for intermediate risk endometrioid adenocarcinoma of the uterus
|
|
|
2004 |
71 |
S2 |
p. S24- 1 p. |
artikel |
74 |
113 oral 125-Iodine prostate brachytherapy & erectile dysfunction-prospective UK data
|
|
|
2004 |
71 |
S2 |
p. S56- 1 p. |
artikel |
75 |
78 oral Is the breast post-operative seroma a reliable guide for planning accelerated partial breast irradiation?
|
|
|
2004 |
71 |
S2 |
p. S39- 1 p. |
artikel |
76 |
19 oral LDR interstitial brachytherapy in the management of carcinoma of the cervix
|
|
|
2004 |
71 |
S2 |
p. S8-S9 2 p. |
artikel |
77 |
53 oral Local control with interstitial brachytherapy implants in patients with carcinoma of the vagina
|
|
|
2004 |
71 |
S2 |
p. S25-S26 2 p. |
artikel |
78 |
34 oral Long term outcome following lodine-125 permanent seed implant for localised prostate cancer: Leeds experience
|
|
|
2004 |
71 |
S2 |
p. S17- 1 p. |
artikel |
79 |
14 oral Long-term results of a randomised trial comparing two preoperative low dose-rates brachytherapy in patients with cervix cancer
|
|
|
2004 |
71 |
S2 |
p. S6-S7 2 p. |
artikel |
80 |
119 oral Long time experience of pulsed brachytherapy in base of tongue cancers
|
|
|
2004 |
71 |
S2 |
p. S59-S60 2 p. |
artikel |
81 |
123 oral Low dose rate intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structures
|
|
|
2004 |
71 |
S2 |
p. S61- 1 p. |
artikel |
82 |
95 oral On-line implant reconstruction in HDR brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S47- 1 p. |
artikel |
83 |
106 oral Outcome and quality of life after HDR brachytherapy in patients with high-risk localized prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S53- 1 p. |
artikel |
84 |
2 oral + poster Current status of brachytherapy facilities and applications in Poland
|
|
|
2004 |
71 |
S2 |
p. S1- 1 p. |
artikel |
85 |
3 oral + poster Patterns of care for brachytherapy in Europe (PCBE): results in Spain
|
|
|
2004 |
71 |
S2 |
p. S1-S2 2 p. |
artikel |
86 |
4 oral + poster Results of the PCBE questionnaire — 2002 in France
|
|
|
2004 |
71 |
S2 |
p. S2- 1 p. |
artikel |
87 |
5 oral + poster Results of the PCBE questionnaire-2002 in The Netherlands
|
|
|
2004 |
71 |
S2 |
p. S2-S3 2 p. |
artikel |
88 |
47 oral Post-operative external beam radiotherapy and vaginal cuff brachytherapy boost for endometrial cancer: survival rates, sites of failure and prognostic factors for recurrence
|
|
|
2004 |
71 |
S2 |
p. S23- 1 p. |
artikel |
89 |
68 oral Pre and post implant dosimetry for Iodine 125 prostate implant: comparison analysis
|
|
|
2004 |
71 |
S2 |
p. S34-S35 2 p. |
artikel |
90 |
51 oral Predictors of treatment outcome after low dose rate temporary interstitial implantation for patients with locally advanced gynaecologic malignancies
|
|
|
2004 |
71 |
S2 |
p. S24-S25 2 p. |
artikel |
91 |
120 oral Primary carcinoma of the oropharynx, relapse and complications: cost analysis comparing brachytherapy versus surgery
|
|
|
2004 |
71 |
S2 |
p. S60- 1 p. |
artikel |
92 |
48 oral Prognostic factors on adjuvant radiotherapy of endometrial carcinoma: experience with external beam radiotherapy and high-dose rate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S23- 1 p. |
artikel |
93 |
38 oral Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or without supplemental external beam radiation
|
|
|
2004 |
71 |
S2 |
p. S18-S19 2 p. |
artikel |
94 |
46 oral Prophylactic vaginal high dose rate brachytherapy after pelvic irradiation in endometrial carcinoma
|
|
|
2004 |
71 |
S2 |
p. S22- 1 p. |
artikel |
95 |
103 oral Prostate brachytherapy toxicity: Leeds experience
|
|
|
2004 |
71 |
S2 |
p. S52- 1 p. |
artikel |
96 |
33 oral Prostate cancer patients treated with external beam radiation therapy combined with I125/Pd103 brachytherapy: Seattle's fifteen year outcome results
|
|
|
2004 |
71 |
S2 |
p. S17- 1 p. |
artikel |
97 |
36 oral Results of high dose rate (HDR) brachytherapy boost for prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S18- 1 p. |
artikel |
98 |
15 oral Retrospectively analysis of 449 cervical cancers treated with high-voltage beam-irradiation (EBRT) and high-dose-rate afterloading (HDR)
|
|
|
2004 |
71 |
S2 |
p. S7- 1 p. |
artikel |
99 |
44 oral Salvage treatment in local relapses after permanent prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S21-S22 2 p. |
artikel |
100 |
75 oral Second conservative treatment for early breast cancer: a non-randomized comparison with mastectomy
|
|
|
2004 |
71 |
S2 |
p. S38- 1 p. |
artikel |
101 |
114 oral Sexual function after permanent implant brachytherapy for prostate cancer : a multivariate analysis
|
|
|
2004 |
71 |
S2 |
p. S56-S57 2 p. |
artikel |
102 |
55 oral Sphincter preservation and brachytherapy for cancer of the rectum: updated results on 52 patients
|
|
|
2004 |
71 |
S2 |
p. S26- 1 p. |
artikel |
103 |
20 oral Systematic evaluation of MRI and clinical findings in cervical cancer at diagnosis and at time of brachytherapy: potential of MRI on delineation of GTV, patho-anatomical structures and organs at risk
|
|
|
2004 |
71 |
S2 |
p. S9- 1 p. |
artikel |
104 |
40 oral The impact of supplemental external beam radiation and/or androgen deprivation therapy on biochemical outcome following permanent prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S19-S20 2 p. |
artikel |
105 |
73 oral TI breast cancer tumors: results of breast-conserving therapy
|
|
|
2004 |
71 |
S2 |
p. S37- 1 p. |
artikel |
106 |
10 oral Time-intregrated DVH for clinical post-implant dosimetric assessments in I-125 permanent prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S4-S5 2 p. |
artikel |
107 |
94 oral TLD dosimetry verification of dose optimisation method used in endovascular brachytherapy of peripheral vessels
|
|
|
2004 |
71 |
S2 |
p. S47- 1 p. |
artikel |
108 |
74 oral Toxicity, local control and cosmesis after interstitial partial breast HDR brachytherapy alone for T1/T2 breast cancer
|
|
|
2004 |
71 |
S2 |
p. S37-S38 2 p. |
artikel |
109 |
1 Patterns of care for brachytherapy in Europe (PCBE)
|
|
|
2004 |
71 |
S2 |
p. S1- 1 p. |
artikel |
110 |
99 PDR brachytherapy in carcinoma of cervix
|
|
|
2004 |
71 |
S2 |
p. S49-S50 2 p. |
artikel |
111 |
60 Permanent seed implantation: the proven choice for your patient
|
|
|
2004 |
71 |
S2 |
p. S30- 1 p. |
artikel |
112 |
28 Pitfalls in the use of TG-43 in brachytherapy treatment planning, some examples
|
|
|
2004 |
71 |
S2 |
p. S14- 1 p. |
artikel |
113 |
133 poster Accelerated partial breast irradiation (APBI): are the current dose prescriptions for brachytherapy and 3D conformal external beam (3D-CRT) equivalent?
|
|
|
2004 |
71 |
S2 |
p. S65-S66 2 p. |
artikel |
114 |
288 poster A comparison of permanent brachytherapy (BT) and 3D conformal radiation therapy (3DCRT) for localized prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S124- 1 p. |
artikel |
115 |
233 poster A comparison of seed coordinates between CT based postplanning and a software based guidance system for intraoperative dosimetry during prostate seed implants
|
|
|
2004 |
71 |
S2 |
p. S103- 1 p. |
artikel |
116 |
313 poster Adjuvant High Dose Rate brachytherapy alone or combined with external beam radiation in endometrial cancer
|
|
|
2004 |
71 |
S2 |
p. S133-S134 2 p. |
artikel |
117 |
321 poster Adjuvant intravaginal high dose rate brachytherapy in endometrial adenocarcinoma
|
|
|
2004 |
71 |
S2 |
p. S136-S137 2 p. |
artikel |
118 |
185 poster A fractionated brachytherapy mold technique can replace IMRT for treatment of a complex shallow target
|
|
|
2004 |
71 |
S2 |
p. S85- 1 p. |
artikel |
119 |
285 poster A MRI based treatment concept for interstitial HDR prostate treatments — Part I: clinical feasibility
|
|
|
2004 |
71 |
S2 |
p. S122-S123 2 p. |
artikel |
120 |
273 poster A MRI based treatment planning concept for interstitial HDR prostate treatments — Part II: dose and volume parameters
|
|
|
2004 |
71 |
S2 |
p. S118-S119 2 p. |
artikel |
121 |
235 poster Anatomy-based inverse planning dose optimization for HDR prostate implant boost: a toxicity report
|
|
|
2004 |
71 |
S2 |
p. S104- 1 p. |
artikel |
122 |
295 poster Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity following permanent interstitial brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S127- 1 p. |
artikel |
123 |
261 poster Androgendeprivation therapy in the management of patients with prostate volumes too large for radioactive seed implantation
|
|
|
2004 |
71 |
S2 |
p. S113-S114 2 p. |
artikel |
124 |
203 poster A newly available radio-isotope with dosimetric and biologic advantages for the treatment of prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S91-S92 2 p. |
artikel |
125 |
139 poster A new methodology for quantitatively measuring conformance index of mammosite catheter implants
|
|
|
2004 |
71 |
S2 |
p. S68- 1 p. |
artikel |
126 |
155 poster Anxiety and depression in gynaecologic cancer patients before, during and after brachytherapy. a randomized study
|
|
|
2004 |
71 |
S2 |
p. S74- 1 p. |
artikel |
127 |
132 poster A phase II randomised trial of partial breast irradiation for early stage breast cancer using the mammosite® radiation therapy system vs. conventional external beam radiotherapy (EBRT)
|
|
|
2004 |
71 |
S2 |
p. S65- 1 p. |
artikel |
128 |
166 poster A pilot phase II trial with Cisplatin — Paclitaxel treatment and concurrent external and endocavitary radiotherapy in locally advanced cervical cancer
|
|
|
2004 |
71 |
S2 |
p. S78- 1 p. |
artikel |
129 |
181 poster Application of the TG-43 dosimetry protocol to electronic brachytherapy sources
|
|
|
2004 |
71 |
S2 |
p. S84- 1 p. |
artikel |
130 |
323 poster A radiobiological model for the relative biological effectiveness of high dose rate Cf-252 brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S137- 1 p. |
artikel |
131 |
320 poster A review of clinical application using Californium-252
|
|
|
2004 |
71 |
S2 |
p. S136- 1 p. |
artikel |
132 |
153 poster A simple method to minimize critical structure irradiation based on analysis of inter-fractional geometric variation in the course of vaginal cuff brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S73-S74 2 p. |
artikel |
133 |
227 poster Assessment of pain and its contributing factors during HDR prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S101- 1 p. |
artikel |
134 |
272 poster Biochemical control and tolerance of HDR brachytherapy and 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S118- 1 p. |
artikel |
135 |
186 poster Bouquet brachytherapy: the feasibility and optimization of conically spaced implants
|
|
|
2004 |
71 |
S2 |
p. S85-S86 2 p. |
artikel |
136 |
329 poster Brachynet — A brachytherapy database and information management system
|
|
|
2004 |
71 |
S2 |
p. S139- 1 p. |
artikel |
137 |
199 poster Brachytherapy in confined prostate cancer treated with I 125, experience in Mexico
|
|
|
2004 |
71 |
S2 |
p. S90- 1 p. |
artikel |
138 |
168 poster Brachytherapy of adenocarcinoma of cervix uteri and endometrial adenocarcinoma
|
|
|
2004 |
71 |
S2 |
p. S79- 1 p. |
artikel |
139 |
246 poster Brachytherapy of prostate cancer in patients with prior colorectal cancer
|
|
|
2004 |
71 |
S2 |
p. S108- 1 p. |
artikel |
140 |
169 poster Brachytherapy of the uterine cervix using 60Co-HDR and 137Cs-MDR
|
|
|
2004 |
71 |
S2 |
p. S79- 1 p. |
artikel |
141 |
292 poster Can we accrue to “difficult” trials in brachytherapy?
|
|
|
2004 |
71 |
S2 |
p. S126- 1 p. |
artikel |
142 |
301 poster Carcinoma of the oral tongue T1-t2 with positive margins. Postoperative brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S129- 1 p. |
artikel |
143 |
167 poster Carcinoma of the uterine cervix: a single institution experience using PDR brachytherapy in 125 consecutive patients
|
|
|
2004 |
71 |
S2 |
p. S78-S79 2 p. |
artikel |
144 |
146 poster Carcinoma of the uterine cervix: moving from LDR to HDR
|
|
|
2004 |
71 |
S2 |
p. S70- 1 p. |
artikel |
145 |
232 poster Catheter reconstruction in TRUS-guided interstitial prostate HDR-brachytherapy under realtime-guidance with the planning system “Swift”
|
|
|
2004 |
71 |
S2 |
p. S103- 1 p. |
artikel |
146 |
282 poster Chronic fatigue after permanent interstitial I-125-brachytherapy, temporary interstitial Ir-192-brachytherapy and external beam radiotherapy for prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S122- 1 p. |
artikel |
147 |
267 poster Clinical benefits of a class solution for inversely planned HDR prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S116- 1 p. |
artikel |
148 |
217 poster Clinical outcome of patients with prostate cancer treated with external beam radiation and iridium sources
|
|
|
2004 |
71 |
S2 |
p. S97- 1 p. |
artikel |
149 |
243 poster Combination of High Dose Rate brachytherapy boost and adjuvant hormonal therapy for prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S107- 1 p. |
artikel |
150 |
239 poster Combined 3-dimensional conformal radiotherapy and interstitial permanent implant for patients with intermediate and unfavourable risk prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S105-S106 2 p. |
artikel |
151 |
151 poster Combined MRI based intracavitary and interstitial brachytherapy for locally advanced cervical cancer with a modified tandem ring applicator — Design, quality assurance and dosimetry
|
|
|
2004 |
71 |
S2 |
p. S72-S73 2 p. |
artikel |
152 |
258 poster Combined surgery and brachytherapy for lymph node negative bladder carcinoma
|
|
|
2004 |
71 |
S2 |
p. S112- 1 p. |
artikel |
153 |
222 poster Combined ultrasound-radiographic approach to the intraoperative detection of seeds in prostate brachytherapy: a feasibility study
|
|
|
2004 |
71 |
S2 |
p. S99-S100 2 p. |
artikel |
154 |
204 poster Comparison of CT and ultrasound based treatment planning for treatment of prostate gland using high dose rate (HDR) brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S92- 1 p. |
artikel |
155 |
212 poster Comparison of dose distribution at the intraprostatic urethra based on interactive dynamic real-time TRUS and CT after permanent seed implantation
|
|
|
2004 |
71 |
S2 |
p. S95- 1 p. |
artikel |
156 |
147 poster Comparison of dose volume histograms of 3-d brachytherapy planning for cervical cancer with empty and full bladder
|
|
|
2004 |
71 |
S2 |
p. S70-S71 2 p. |
artikel |
157 |
260 poster Comparison of perioperative morbidity and acute toxicity in prostate HDR brachytherapy with permanent seed implants
|
|
|
2004 |
71 |
S2 |
p. S113- 1 p. |
artikel |
158 |
290 poster Comparison of race and prostate cancer outcome in patients treated with brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S125- 1 p. |
artikel |
159 |
331 poster Comparison of results with external beam irradiation (EBI) or EBI + interstitial high dose rate (HDR) brachytherapy (BT) in the treatment of base of tongue tumors
|
|
|
2004 |
71 |
S2 |
p. S140- 1 p. |
artikel |
160 |
224 poster Comparison of virtual and live plans in -real time-brachytherapy inprostate cancer based on ultrasound examination
|
|
|
2004 |
71 |
S2 |
p. S100- 1 p. |
artikel |
161 |
138 poster Conformal peroperative interstitial sole brachytherapy of early stage breast carcinoma using the HDR afterloading
|
|
|
2004 |
71 |
S2 |
p. S67- 1 p. |
artikel |
162 |
201 poster Conformance of the seedselectron to manufacturer specifications and ABS/AAPM recommendations
|
|
|
2004 |
71 |
S2 |
p. S91- 1 p. |
artikel |
163 |
225 poster Conformity error: a new method for evaluating the conformity of interstitial brachytherapy implants
|
|
|
2004 |
71 |
S2 |
p. S100-S101 2 p. |
artikel |
164 |
322 poster Conservative treatment of intra-ocular melanoma with Iodine-125 brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S137- 1 p. |
artikel |
165 |
252 poster Coverage of extra-capsular extension (ECE) with three dimensional conformal external beam radiotherapy (3DCRT) or permanent prostate seed implantation (PPI)
|
|
|
2004 |
71 |
S2 |
p. S110-S111 2 p. |
artikel |
166 |
165 poster CT based dose distribution and optimization for gynaecological pulsed dose rate interstitial brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S78- 1 p. |
artikel |
167 |
142 poster CT-based treatment planning in mammosite brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S69- 1 p. |
artikel |
168 |
144 poster CT computer-optimized HDR surface applicator brachytherapy provides a more homogeneous scar boost dose than electrons following breast reconstruction
|
|
|
2004 |
71 |
S2 |
p. S69-S70 2 p. |
artikel |
169 |
316 poster CT images versus simulator images for dose planning of head & neck tumours
|
|
|
2004 |
71 |
S2 |
p. S135- 1 p. |
artikel |
170 |
294 poster CT, MRI, and CT-MRI image fusion assessment for prostate I-125 post implant dosimetry
|
|
|
2004 |
71 |
S2 |
p. S126-S127 2 p. |
artikel |
171 |
229 poster Deciding on a treatment for prostate cancer: how and why menchoose high dose rate (HDR) brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S102- 1 p. |
artikel |
172 |
247 poster Detection of local recurrence after J-125 permanent brachytherapy of the prostate by 11C-Cholin-PET-CT and consequences for therapy
|
|
|
2004 |
71 |
S2 |
p. S108-S109 2 p. |
artikel |
173 |
176 poster Development of a field-customizable neural network nomogram equivalent
|
|
|
2004 |
71 |
S2 |
p. S82- 1 p. |
artikel |
174 |
87 poster dis Acute urinary retention following magnetic-resonance-image-guided prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S43-S44 2 p. |
artikel |
175 |
86 poster dis A prospective study of PSA bounce following Iodine-125 brachytherapy in low risk prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S43- 1 p. |
artikel |
176 |
81 poster dis Design of a web page with the dosimetric parameters for all the different models of Cs-137 and Ir-192 sources used in brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S41- 1 p. |
artikel |
177 |
80 poster dis Dosimetric comparisons between MammoSite HDR brachytherapy and conventional electron boost after external beam radiotherapyfor early-stage breast cancer
|
|
|
2004 |
71 |
S2 |
p. S41- 1 p. |
artikel |
178 |
82 poster dis Individualized vaginal moulds for LDR Iridium-192. Results in 55 patients
|
|
|
2004 |
71 |
S2 |
p. S41-S42 2 p. |
artikel |
179 |
88 poster dis Influence of source strength on outcomes in patients undergoing prostate I-125 seed implants for prostate carcinoma
|
|
|
2004 |
71 |
S2 |
p. S44- 1 p. |
artikel |
180 |
91 poster dis Intraoperative real-time planning for HDR brachytherapy as monotherapy in early stage prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S45- 1 p. |
artikel |
181 |
89 poster dis Iodine-125 prostate brachytherapy in localized prostate cancer: importance of team experience for dose delivery ad toxicity
|
|
|
2004 |
71 |
S2 |
p. S44-S45 2 p. |
artikel |
182 |
85 poster dis PSA results after Iodine seed prostate brachytherapy in the UK with up to five years follow up
|
|
|
2004 |
71 |
S2 |
p. S43- 1 p. |
artikel |
183 |
83 poster dis Pulsed dose rate (PDR) intraoperative brachytherapy in soft tissue sarcomas : a retrospective study of 30 patients
|
|
|
2004 |
71 |
S2 |
p. S42- 1 p. |
artikel |
184 |
84 poster dis Squamous cell carcinoma of the lip and interstitial low dose rate brachytherapy (LDR). Evaluation of prognostic factors and estetic results
|
|
|
2004 |
71 |
S2 |
p. S42-S43 2 p. |
artikel |
185 |
90 poster dis Use of magnetic resonance imaging and spectroscopy to compare the metabolic response of the prostate following external beam radiation therapy and permanent prostate implants for early stage prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S45- 1 p. |
artikel |
186 |
245 poster Does anaesthesia method impact implant-induced swelling of the prostate?
|
|
|
2004 |
71 |
S2 |
p. S108- 1 p. |
artikel |
187 |
257 poster Does cigarette smoking influence biochemical outcome following permanent prostate brachytherapy?
|
|
|
2004 |
71 |
S2 |
p. S112- 1 p. |
artikel |
188 |
269 poster Dose-effect relationship for grade-2 urethral toxicity in permanent prostate implants
|
|
|
2004 |
71 |
S2 |
p. S117- 1 p. |
artikel |
189 |
297 poster Dose escalation by HDR brachytherapy in intermediate or high risk localized prostate cancer: early toxicity and biochemical outcome of a pilot study
|
|
|
2004 |
71 |
S2 |
p. S128- 1 p. |
artikel |
190 |
183 poster Dose response of gafchromic XR-T film to a new electronic brachytherapy source
|
|
|
2004 |
71 |
S2 |
p. S84-S85 2 p. |
artikel |
191 |
283 poster Dose-volume-time-impact on toxicity in interstitial temporary HDR-Ir-192-brachytherapy (BT) for prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S122- 1 p. |
artikel |
192 |
182 poster Dosimetric study of the 15 mm ropes eye plaque
|
|
|
2004 |
71 |
S2 |
p. S84- 1 p. |
artikel |
193 |
244 poster Dosimetry of high dose rate (HDR) brachytherapy is highly reliable
|
|
|
2004 |
71 |
S2 |
p. S107-S108 2 p. |
artikel |
194 |
305 poster Early stage carcinomas of the mobile tongue: influence of modality treatment (curietherapy versus external irradiation combined with curietherapy) on local control and survival
|
|
|
2004 |
71 |
S2 |
p. S131- 1 p. |
artikel |
195 |
326 poster Effect and toxicity of palliative HDR and PDR brachytherapy in patients with recurrent head and neck cancer
|
|
|
2004 |
71 |
S2 |
p. S138- 1 p. |
artikel |
196 |
310 poster Effects of interstitial PDR and CLDR brachytherapy on cell cycle progression in a syngeneic rat prostate tumor model
|
|
|
2004 |
71 |
S2 |
p. S132-S133 2 p. |
artikel |
197 |
208 poster Efficiency of manual and automatic seed delivery in permanent prostate implants
|
|
|
2004 |
71 |
S2 |
p. S93- 1 p. |
artikel |
198 |
140 poster Electronic (non-isotopic) high dose rate brachytherapy (EHDRB): design, characterization and pilot animal trial of a novel method of accelerated partial breast irradiation
|
|
|
2004 |
71 |
S2 |
p. S68- 1 p. |
artikel |
199 |
194 poster Enzymatic prostatic acid phosphatase in the clinical staging of patients with newly diagnosed, untreated prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S88-S89 2 p. |
artikel |
200 |
172 poster Evaluation of technical failures during treatment in pulsed dose rate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S80-S81 2 p. |
artikel |
201 |
191 poster Experience associated with the verification of the reference air kerma rate of I-125 seeds
|
|
|
2004 |
71 |
S2 |
p. S87-S88 2 p. |
artikel |
202 |
154 poster Experience with high-dose-rate brachytherapy (HDR) in carcinoma uterine cervix in the department of Radiation Oncology of Hospital Carlos Haya in Malaga (Spain)
|
|
|
2004 |
71 |
S2 |
p. S74- 1 p. |
artikel |
203 |
240 poster Extending protection of organ at risk to the bulb of the penis yields conformal treatment plans and lower D70% and D50% bulb doses with inverse planned simulated annealing (IPSA) high dose rate (HDR) brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S106- 1 p. |
artikel |
204 |
205 poster Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S92- 1 p. |
artikel |
205 |
231 poster First experiences with dynamic interactive realtime dose verification during transperineal permanent seed implantation (TPSI) of patients with “low risk” prostate cancer in an outpatient setting
|
|
|
2004 |
71 |
S2 |
p. S102-S103 2 p. |
artikel |
206 |
215 poster First results of brachytherapy for prostate cancer with J-125-seeds using the nucletron first™ system
|
|
|
2004 |
71 |
S2 |
p. S96- 1 p. |
artikel |
207 |
162 poster First results of chemoradiation in cervical cancers with high dose rate brachytherapy combined with external beam radiotherapy
|
|
|
2004 |
71 |
S2 |
p. S76-S77 2 p. |
artikel |
208 |
263 poster HDR-afterloading in locally advanced prostate cancer in an outpatient setting — experience of an interdisciplinary prostate center
|
|
|
2004 |
71 |
S2 |
p. S114- 1 p. |
artikel |
209 |
318 poster HDR and LDR brachytherapy in the treatment of paediatric tumours. A single institution experience on 21 patients
|
|
|
2004 |
71 |
S2 |
p. S135-S136 2 p. |
artikel |
210 |
210 poster HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation for unfavourable stage prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S94- 1 p. |
artikel |
211 |
128 poster HDR/PDR interstitial intensity modulated brachytherapy for local recurrences of the breast/thoracic wall following breast cancer
|
|
|
2004 |
71 |
S2 |
p. S63- 1 p. |
artikel |
212 |
279 poster Health related quality of life in low to high-risk prostate cancer patients treaded by brachytherapy and 3D conformal radiotherapy
|
|
|
2004 |
71 |
S2 |
p. S121- 1 p. |
artikel |
213 |
312 poster High dose rate brachytherapy as conservative treatment for vulvar cancer
|
|
|
2004 |
71 |
S2 |
p. S133- 1 p. |
artikel |
214 |
141 poster High dose rate brachytherapy boost in breast-conserving surgery: skin-sparing and target determination
|
|
|
2004 |
71 |
S2 |
p. S68- 1 p. |
artikel |
215 |
299 poster High dose rate brachytherapy (HDR) in endometrium carcinoma. Carlos Haya Hospital Experience in Malaga (Spain)
|
|
|
2004 |
71 |
S2 |
p. S128-S129 2 p. |
artikel |
216 |
131 poster High dose rate brachytherapy in conservative treatment of breast cancer. An ambulatory method. Analysis of results
|
|
|
2004 |
71 |
S2 |
p. S64-S65 2 p. |
artikel |
217 |
327 poster High dose rate endobronchial brachytherapy in the management of advanced lung cancer — Comparison of different protocols
|
|
|
2004 |
71 |
S2 |
p. S138-S139 2 p. |
artikel |
218 |
306 poster High dose rate (HDR) brachytherapy treatment for skin cancer
|
|
|
2004 |
71 |
S2 |
p. S131- 1 p. |
artikel |
219 |
148 poster High (HDR) and low dose rates (LDR) brachytherapy (BT): comparison of side-effects and survival
|
|
|
2004 |
71 |
S2 |
p. S71- 1 p. |
artikel |
220 |
287 poster I-125 isodose patterns as predictors of inadequate prostate brachytherapy dose coverage
|
|
|
2004 |
71 |
S2 |
p. S123-S124 2 p. |
artikel |
221 |
242 poster Image-fusion based CT pre and post-implant in seed implantation: a useful tool for accurate prostate definition in the post-planning setting
|
|
|
2004 |
71 |
S2 |
p. S107- 1 p. |
artikel |
222 |
315 poster Image fusion of CT and MRI data enables improved target volume definition in 3d-brachytherapy treatment planning
|
|
|
2004 |
71 |
S2 |
p. S134- 1 p. |
artikel |
223 |
266 poster Improved dosimetry by the use of a unique interactive image registered intra- operative treatment planning system for permanent seed brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S115-S116 2 p. |
artikel |
224 |
220 poster Improved patient education for prostate brachytherapy using web-based paling diagrams for graphical representation of data
|
|
|
2004 |
71 |
S2 |
p. S98-S99 2 p. |
artikel |
225 |
157 poster Increasing the dose rate of medium dose rate brachytherapy in the definitive radiation treatment of advanced cervical carcinoma: impact on local control and late complications
|
|
|
2004 |
71 |
S2 |
p. S75- 1 p. |
artikel |
226 |
197 poster Intermediate results of ferromagnetic thermal ablation for radiation failure local recurrence of prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S89-S90 2 p. |
artikel |
227 |
150 poster Interstitial brachytherapy (MUPIT) in gynaecologic tumors: results and toxicity analysis
|
|
|
2004 |
71 |
S2 |
p. S72- 1 p. |
artikel |
228 |
302 poster Interstitial HDR-brachytherapy in patients with oral cavity and oropharyngeal cancer -treatment results and complications based upon material of Institute of Oncology in Gliwice
|
|
|
2004 |
71 |
S2 |
p. S129-S130 2 p. |
artikel |
229 |
328 poster Intraluminal pulsed dose rate (PDR) brachytherapy for locally advanced bile ducts cancer: a case report
|
|
|
2004 |
71 |
S2 |
p. S139- 1 p. |
artikel |
230 |
223 poster Intraoperative brachytherapy technique of low dose rate with 125I in real time and by dynamic calculation
|
|
|
2004 |
71 |
S2 |
p. S100- 1 p. |
artikel |
231 |
253 poster Introduction of the seed selectron for automatic seed delivery in permanent prostate implants
|
|
|
2004 |
71 |
S2 |
p. S111- 1 p. |
artikel |
232 |
226 poster Iodine 125 brachytherapy for prostate cancer in Ravenna (Italy)
|
|
|
2004 |
71 |
S2 |
p. S101- 1 p. |
artikel |
233 |
268 poster 125 I RAPIDStrand transperineal TRUS-guided prostate brachytherapy: A prospective comparison of low versus high activity sources
|
|
|
2004 |
71 |
S2 |
p. S116-S117 2 p. |
artikel |
234 |
293 poster I125 re-implantation in patients with poor initial dosimetry after prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S126- 1 p. |
artikel |
235 |
289 poster 192Ir LDR Brachytherapy(BT) is at least as efficient as HDR options for boosting intermediate or unfavourable prostate cancers after EBRT. Experience on 201 patients
|
|
|
2004 |
71 |
S2 |
p. S124-S125 2 p. |
artikel |
236 |
130 poster Long-term results of chest wall reirradiation using pulsed dose rate (PDR) brachytherapy moulds for breast cancer local recurrences
|
|
|
2004 |
71 |
S2 |
p. S64- 1 p. |
artikel |
237 |
156 poster Magnetic resonance evaluation based mdifications of standard brachytherapy technique in cervical cancer treatment
|
|
|
2004 |
71 |
S2 |
p. S75- 1 p. |
artikel |
238 |
206 poster Measurement of urethral dose profiles in prostate brachytherapy using a linear Mosfet array dosimeter
|
|
|
2004 |
71 |
S2 |
p. S92-S93 2 p. |
artikel |
239 |
324 poster MEDARPA —Implantation of brachytherapy-catheters using augmented reality
|
|
|
2004 |
71 |
S2 |
p. S137- 1 p. |
artikel |
240 |
159 poster Medium and high dose rate brachytherapy for cervix cancer : experience of study group — Brazilian institutions
|
|
|
2004 |
71 |
S2 |
p. S76- 1 p. |
artikel |
241 |
274 poster Minimal displacement of self-anchoring brachytherapy catheters in temporary prostate implants
|
|
|
2004 |
71 |
S2 |
p. S119- 1 p. |
artikel |
242 |
214 poster Mixed stranded & free I-125 sources for permanent prostate implant
|
|
|
2004 |
71 |
S2 |
p. S95-S96 2 p. |
artikel |
243 |
149 poster MRI based treatment planning in cervical cancer brachytherapy : characteristics of the 2 cm3 volume receiving the highest dose in bladder and rectum walls, compared with ICRU reference points
|
|
|
2004 |
71 |
S2 |
p. S71-S72 2 p. |
artikel |
244 |
219 poster MRI-Guided HDR prostate brachytherapy in a Standard 1.5T Scanner
|
|
|
2004 |
71 |
S2 |
p. S98- 1 p. |
artikel |
245 |
152 poster MRI-guided treatment planning for cervical cancer patients treated with a combination of external beam radiotherapy and PDR-brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S73- 1 p. |
artikel |
246 |
298 poster Multi phase radical treatment of anal cancer using concurrent chemo radiation and interstitial brachytherapy boost- Clatterbridge experience
|
|
|
2004 |
71 |
S2 |
p. S128- 1 p. |
artikel |
247 |
325 poster Neutron brachytherapy with Cf-252 low-dose-rate and concurrent chemotherapy in the treatment of primary cancer of the oral cavity
|
|
|
2004 |
71 |
S2 |
p. S138- 1 p. |
artikel |
248 |
271 poster Number of catheters in prostate high dose rate brachytherapy: the role of inverse planning
|
|
|
2004 |
71 |
S2 |
p. S117-S118 2 p. |
artikel |
249 |
330 poster Oesophageal fistula formation following oesophageal wall resection and permanent radioactive seed implantation for mediastinal carcinoid tumors
|
|
|
2004 |
71 |
S2 |
p. S139-S140 2 p. |
artikel |
250 |
158 poster One or two MDR-brachytherapy fractions inthe treatment of locally advanced cervical carcinoma
|
|
|
2004 |
71 |
S2 |
p. S75- 1 p. |
artikel |
251 |
286 poster Organ contouring in permanent prostate brachytherapy (PPB) post-implant evaluation: a multicentric study
|
|
|
2004 |
71 |
S2 |
p. S123- 1 p. |
artikel |
252 |
134 poster Partial breast brachytherapy using multiple dwell positions in a single channel interstitial device — mammosite
|
|
|
2004 |
71 |
S2 |
p. S66- 1 p. |
artikel |
253 |
135 poster Partial breast high dose rate (HDR) brachytherapy: a preliminary prospective study
|
|
|
2004 |
71 |
S2 |
p. S66- 1 p. |
artikel |
254 |
143 poster Partial breast irradiation using mammosite RTS: preliminary results of a single institution phase II pilot study
|
|
|
2004 |
71 |
S2 |
p. S69- 1 p. |
artikel |
255 |
190 poster 32P endovascular brachytherapy source experimental dosimetry
|
|
|
2004 |
71 |
S2 |
p. S87- 1 p. |
artikel |
256 |
177 poster Percent depth dose for a sphere of 32p chromic phosphorous colloid
|
|
|
2004 |
71 |
S2 |
p. S82- 1 p. |
artikel |
257 |
270 poster Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA 20 ng/ml
|
|
|
2004 |
71 |
S2 |
p. S117- 1 p. |
artikel |
258 |
296 poster Permanent interstitial brachytherapy for younger patients with clinically organ-confined prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S127-S128 2 p. |
artikel |
259 |
198 poster Permanent I-125 prostatic seed implantation technique in a University Hospital. Preliminary results
|
|
|
2004 |
71 |
S2 |
p. S90- 1 p. |
artikel |
260 |
228 poster Permanent J-125 brachytherapy of localized prostate cancer — Quality of life and local control
|
|
|
2004 |
71 |
S2 |
p. S101-S102 2 p. |
artikel |
261 |
250 poster Permanent prostate brachytherapy as a second curative treatment in patients with local recurrences following external irradiation
|
|
|
2004 |
71 |
S2 |
p. S110- 1 p. |
artikel |
262 |
248 poster Permanent prostate gland seed implant: a comparison of dosimetry outcome between loose-seeds and rapid strand brachytherapy techniques
|
|
|
2004 |
71 |
S2 |
p. S109- 1 p. |
artikel |
263 |
304 poster Permanent prostate implants: information guide for patient and relatives
|
|
|
2004 |
71 |
S2 |
p. S130- 1 p. |
artikel |
264 |
291 poster Permanent prostate implant using high activity seeds and inverse planning with fast simulated annealing algorithm: an early Canadian experience
|
|
|
2004 |
71 |
S2 |
p. S125-S126 2 p. |
artikel |
265 |
173 poster Phantom size in brachytherapy source dosimetric studies
|
|
|
2004 |
71 |
S2 |
p. S81- 1 p. |
artikel |
266 |
163 poster Positional stability of Töre's applicator and dose variations with time during LDR brachytherapy for cervical carcinoma
|
|
|
2004 |
71 |
S2 |
p. S77- 1 p. |
artikel |
267 |
174 poster Practising the LD dosimetry concept for permanent prostatic seed implants
|
|
|
2004 |
71 |
S2 |
p. S81- 1 p. |
artikel |
268 |
136 poster Preliminary results of Pulsed Dose Rate peri-operative Brachytherapy (PDR BT) as an interstitial boost in conservative treatment (BCT) of breast cancer
|
|
|
2004 |
71 |
S2 |
p. S66-S67 2 p. |
artikel |
269 |
161 poster Preoperative concurrent radiotherapy and chemotherapy in uterine cervix cancer
|
|
|
2004 |
71 |
S2 |
p. S76- 1 p. |
artikel |
270 |
216 poster Prevention of prostate HDR needle dislocation using the brachybench, a secure, comfortable, “air-ride”, patient positioning and transfer device
|
|
|
2004 |
71 |
S2 |
p. S96- 1 p. |
artikel |
271 |
145 poster Prognostic factor analysis in primary radiotherapy of cervical carcinoma
|
|
|
2004 |
71 |
S2 |
p. S70- 1 p. |
artikel |
272 |
251 poster Prospective evaluation of urinary morbidity following permanent interstitial brachytherapy for localized prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S110- 1 p. |
artikel |
273 |
218 poster Prostate brachytherapy with 125 I. Results of 45 patients treated at the Hospital de la Santa Creu i Sant Pau. Can dosimetric parameters predict the clinical outcome?
|
|
|
2004 |
71 |
S2 |
p. S97-S98 2 p. |
artikel |
274 |
202 poster Prostate HDR brachytherapy. An outpatient approach
|
|
|
2004 |
71 |
S2 |
p. S91- 1 p. |
artikel |
275 |
311 poster Prostate specific antigen bounce after hormonal ablation, external beam radiation therapy and high dose rate brachytherapy in the treatment of prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S133- 1 p. |
artikel |
276 |
179 poster Protecting the urethra in prostate HDR brachytherapy: the template geometry does matter
|
|
|
2004 |
71 |
S2 |
p. S83- 1 p. |
artikel |
277 |
200 poster PSA bounce after transperineal iodine prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S91- 1 p. |
artikel |
278 |
319 poster Pulsed dose-brachytherapy of oropharyngeal carcinomas
|
|
|
2004 |
71 |
S2 |
p. S136- 1 p. |
artikel |
279 |
241 poster Quality assurance for fractionated high dose rate afterloading brachytherapy as monotherapy for prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S106-S107 2 p. |
artikel |
280 |
249 poster Quality assurance in HDR brachytherapy for prostate cancer: how can prostate displacement be minimized?
|
|
|
2004 |
71 |
S2 |
p. S109- 1 p. |
artikel |
281 |
188 poster Quality assurance of a high dose rate afterloader
|
|
|
2004 |
71 |
S2 |
p. S86- 1 p. |
artikel |
282 |
187 poster Quality Assurance of Treament Planning System (TPS) in Low Dose Rate Brachytherapy (LDR) using Thermoluminescence Dosimetry (LiF)
|
|
|
2004 |
71 |
S2 |
p. S86- 1 p. |
artikel |
283 |
262 poster Quality of dose distribution with realtime-plan-modification (RPM) in permanent seed implants
|
|
|
2004 |
71 |
S2 |
p. S114- 1 p. |
artikel |
284 |
264 poster Quality of implant dosimetry for intraoperative versus preoperative planning for permanent prostate seed implants: are there differences in coverage of the base, mid-zone and apex of the prostate?
|
|
|
2004 |
71 |
S2 |
p. S114-S115 2 p. |
artikel |
285 |
276 poster Quality of life after prostate brachytherapy: a prospective study
|
|
|
2004 |
71 |
S2 |
p. S120- 1 p. |
artikel |
286 |
178 poster Radiation safety after permanent prostate brachyterapy
|
|
|
2004 |
71 |
S2 |
p. S83- 1 p. |
artikel |
287 |
280 poster 1251 RAPIDStrand versus 103Pd for localized prostate cancer: A dosimetric analysis
|
|
|
2004 |
71 |
S2 |
p. S121- 1 p. |
artikel |
288 |
314 poster Real-time intraoperative orientation for interstitial brachytherapy needle implantation using augmented reality
|
|
|
2004 |
71 |
S2 |
p. S134- 1 p. |
artikel |
289 |
213 poster Real time prostate implant with rapid strand I125 seeds. the experience with 43 patients treated in 2003
|
|
|
2004 |
71 |
S2 |
p. S95- 1 p. |
artikel |
290 |
254 poster Reliability of CT-based postimplant dose values in interstitial permanent brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S111- 1 p. |
artikel |
291 |
164 poster Remote afterloading for HDR neutron brachytherapy with Californium-252
|
|
|
2004 |
71 |
S2 |
p. S77-S78 2 p. |
artikel |
292 |
160 poster Results of cervical carcinoma treated with external Radiotherapy and High Dose Rate Brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S76- 1 p. |
artikel |
293 |
255 poster Salvage combined intensity modulated HDR brachytherapy and external beam treatment (EBRT) for local recurrences after radical prostatectomy: first results of a prospective feasibility & dose escalation study
|
|
|
2004 |
71 |
S2 |
p. S111-S112 2 p. |
artikel |
294 |
180 poster Silicon detector versus gafchromic film for brachytherapy sources characterisation
|
|
|
2004 |
71 |
S2 |
p. S83-S84 2 p. |
artikel |
295 |
196 poster Simplified data analysis with a relational database dedicated to prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S89- 1 p. |
artikel |
296 |
137 poster Single fraction boost with high dose rate brachytherapy in breast conserving therapy
|
|
|
2004 |
71 |
S2 |
p. S67- 1 p. |
artikel |
297 |
129 poster Skin ellipse technique for mammosite® device placement
|
|
|
2004 |
71 |
S2 |
p. S64- 1 p. |
artikel |
298 |
278 poster Targeting dominant intraprostatic lesion using functional imaging with MR spectroscopy and high dose rate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S120-S121 2 p. |
artikel |
299 |
281 poster Temporal effect of neoadjuvant androgen deprivation therapy on PSA kinetics following permanent prostate brachytherapy with or without supplemental external beam radiation
|
|
|
2004 |
71 |
S2 |
p. S121-S122 2 p. |
artikel |
300 |
184 poster The angular homogeneity index, a tool for greater precision and accuracy in the assessment of homogeneity
|
|
|
2004 |
71 |
S2 |
p. S85- 1 p. |
artikel |
301 |
236 poster The applicability of simultaneous CT-US imaging for the evaluation of prostate implants
|
|
|
2004 |
71 |
S2 |
p. S104-S105 2 p. |
artikel |
302 |
175 poster The BCCA's HDR breast brachytherapy program — A physicist's view
|
|
|
2004 |
71 |
S2 |
p. S81-S82 2 p. |
artikel |
303 |
207 poster The benefits provided by using intra-operative dosimetry and the fusion of MRI to CT for post plan dosimetry in the learning curve of transperineal interstitial permanent prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S93- 1 p. |
artikel |
304 |
193 poster The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S88- 1 p. |
artikel |
305 |
127 poster The dose volume relationship of lung and cardiac tissue in single source breast brachytherapy compared to external beam tangent fields for subclinical physiologic changes
|
|
|
2004 |
71 |
S2 |
p. S63- 1 p. |
artikel |
306 |
259 poster The impact of anatomic challenges on HDR dosimetry and implant toxicity
|
|
|
2004 |
71 |
S2 |
p. S113- 1 p. |
artikel |
307 |
211 poster The impact of intra-operative delivery accuracy on intra-operative and post-operative dosimetry for prostate treatments using a low dose-rate iodine-125 remote afterloader
|
|
|
2004 |
71 |
S2 |
p. S94-S95 2 p. |
artikel |
308 |
189 poster The impact of number of the Norman Simon (NS) applicators on dose distribution in endometrial cancer patients treated with pulsed dose rate brachytherapy (PDR BT)
|
|
|
2004 |
71 |
S2 |
p. S86-S87 2 p. |
artikel |
309 |
195 poster The impact of prostate volume and neoadjuvant androgen deprivation therapy on urinary function following prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S89- 1 p. |
artikel |
310 |
265 poster The influence of low dose regions on D90 values in permanent prostate implants
|
|
|
2004 |
71 |
S2 |
p. S115- 1 p. |
artikel |
311 |
300 poster The intracoronary brachytherapy for in-stent restenosis: clinical and film dosimetric results
|
|
|
2004 |
71 |
S2 |
p. S129- 1 p. |
artikel |
312 |
309 poster The role of external beam radiotherapy and brachytherapy in the treatment of bile duct and gall bladder tumors
|
|
|
2004 |
71 |
S2 |
p. S132- 1 p. |
artikel |
313 |
307 poster The role of high dose rate endobronchial brachytherapy in the palliation of patients with non-small cell lung cancer: a practice-guideline
|
|
|
2004 |
71 |
S2 |
p. S131-S132 2 p. |
artikel |
314 |
317 poster The role of high dose rate (HDR) brachytherapy in the management of soft tissue sarcomas
|
|
|
2004 |
71 |
S2 |
p. S135- 1 p. |
artikel |
315 |
277 poster The role of prophylactic tamsulosin(Flomax®) ± dexamethasone in patients undergoing prostate 125I seed implants for prostate carcinoma. A randomized double blind study
|
|
|
2004 |
71 |
S2 |
p. S120- 1 p. |
artikel |
316 |
209 poster The use of fiducial markers for verification of catheter position in HDR prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S93-S94 2 p. |
artikel |
317 |
192 poster Three dimensional dose distribution in pulsed dose rate oropharyngeal brachytherapy : comparison of 3 methods : non optimization, dose point optimization and inverse optimization
|
|
|
2004 |
71 |
S2 |
p. S88- 1 p. |
artikel |
318 |
303 poster Three dimension conformal brachytherapy for medically inoperable endometrial carcinomas helps to define small bowel risk of toxicity
|
|
|
2004 |
71 |
S2 |
p. S130- 1 p. |
artikel |
319 |
308 poster Treatment of unresectable rectal cancers
|
|
|
2004 |
71 |
S2 |
p. S132- 1 p. |
artikel |
320 |
238 poster TRUS- and CT-image fusion“ in the postplanning procedure after transperineal permanent interstitial seedimplantation (TPSI) of “low risk” prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S105- 1 p. |
artikel |
321 |
332 poster Update of HDR-brachytherapy for non-malignant obstruction in lung transplant bronchi: two years experiences
|
|
|
2004 |
71 |
S2 |
p. S140- 1 p. |
artikel |
322 |
237 poster Urethral geometric sparing factor for HDR prostate brachytherapy
|
|
|
2004 |
71 |
S2 |
p. S105- 1 p. |
artikel |
323 |
234 poster Urinary function after prostate brachytherapy with rapid-strand 125-I in low-risk prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S104- 1 p. |
artikel |
324 |
275 poster Urinary toxicity when using high dose rate prostate brachytherapy as a boost to conventional external beam radiation therapy in localized prostate cancer
|
|
|
2004 |
71 |
S2 |
p. S119- 1 p. |
artikel |
325 |
230 poster Variation regarding the calibration certificate and uncertainties in the calibration of air-kerma strength reference (AKSR) of Amersham 6711 Iodine-125 seeds
|
|
|
2004 |
71 |
S2 |
p. S102- 1 p. |
artikel |
326 |
221 poster What percent of seeds need to be detected for effective intraoperative dosimetry during permanent prostate brachytherapy?
|
|
|
2004 |
71 |
S2 |
p. S99- 1 p. |
artikel |
327 |
31 Primary standards for brachytherapy sources, emitting betas and low energy photons
|
|
|
2004 |
71 |
S2 |
p. S15- 1 p. |
artikel |
328 |
102 Reporting time-dose pattern in intra-cavitary brachytherapy. Considerations on a common language using the linear quadratic model
|
|
|
2004 |
71 |
S2 |
p. S50-S51 2 p. |
artikel |
329 |
30 The differences in approach to source calibration between the US and the EU
|
|
|
2004 |
71 |
S2 |
p. S15- 1 p. |
artikel |
330 |
101 The role of radiobiology in the management of cervix cancer
|
|
|
2004 |
71 |
S2 |
p. S50- 1 p. |
artikel |
331 |
62 Three year update of results with the MammoSite breast brachytherapy applicator
|
|
|
2004 |
71 |
S2 |
p. S31- 1 p. |
artikel |